Accelrys Reports World Class Customer Satisfaction for its Scientific Operating Platform
News Oct 04, 2006
Accelrys has announced that SciTegic, the platform and solutions division of Accelrys, has received the highest customer satisfaction ratings measured last year by independent customer research-based consultants, TNS Prognostics.
Through extensive surveys of over 250 customers, the study concluded that the SciTegic Division had 99.1% satisfied customers and the highest customer loyalty scores seen by TNS last year.
The importance of overall product quality was confirmed by users of the SciTegic scientific operating platform with 77% of respondents citing the quality of the product as the leading reason for their favourable reference.
Discovery Studio® 1.6, the most recent version of Accelrys’ suite of life science modelling and simulation tools for lead discovery and optimisation includes the integration of the scientific operating platform.
The combination of Discovery Studio 1.6 and Pipeline Pilot provides the ability to create and manage computational protocols that capture and automate data processing routines.
"Our scientific operating platform is fundamental to the long term strategy of Accelrys," said Matt Hahn, PhD, founder of SciTegic and Accelrys Vice President of Platform Strategy and Technology.
"Receiving such high customer satisfaction results reaffirms that our technology and our solutions team provide immense value to our customers."
"Accelrys is leveraging the relationships that SciTegic has had with customers and this customer-centric focus is essential to our continued success."
"As the leading provider of scientific software and service solutions, we're honoured to be recognised for delivering excellence in customer satisfaction."
Other Accelrys solutions incorporate the scientific operating platform. The extensive customisation capabilities of the platform allow both Accelrys and end users to create and deploy domain-tailored applications.
Ingestible Drug-Delivery Materials May Improve Patient Treatment ComplianceNews
Hydrogel-based capsules could expand and reside in the GI tract for days, slowly releasing medication.READ MORE
Researchers Develop New Method to Generate Human AntibodiesNews
Researchers hope their approach will help researchers rapidly generate therapeutic antibodies for the treatment of infectious diseases and other conditions such as cancer.READ MORE
Large-Scale Production of Living Brain Cells Enables Entirely New ResearchNews
After performing a biopsy on the patient, the skin cells are transformed into brain cells that effectively imitate the disease and the age of the patient.READ MORE
Comments | 0 ADD COMMENT
International Conference and Exhibition on Nanomedicine and Nanotechnology
Nov 23 - Nov 24, 2017
EMBL Conference: European Conference of Life Science Funders and Foundations
Apr 19 - Apr 20, 2018